SUSAN WEITZ JAFFE
Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology ROCKVILLE, MD NPI 1851359632
Browse related groups: Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology MD SHIELD THERAPEUTICS INC All categories
General Payments — all program years on this page
$775.40
- Category: General Payments
- Program years: PY2018–2024
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $178.94 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.94 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $32.16 | 1 |
| ABBVIE INC. | $30.27 | 2 |
| Janssen Biotech, Inc. | $25.18 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.64 | 1 |
| AKEBIA THERAPEUTICS INC | $23.72 | 1 |
| PFIZER INC. | $21.95 | 1 |
| GENZYME CORPORATION | $21.02 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078728857 | Janssen Biotech, Inc. | $25.18 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103981500 | ABBVIE INC. | $16.22 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103981502 | ABBVIE INC. | $14.05 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131372008 | PFIZER INC. | $21.95 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139580322 | GENZYME CORPORATION | $21.02 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144614911 | Xeris Pharmaceuticals, Inc. | $24.64 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145827008 | AKEBIA THERAPEUTICS INC | $23.72 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150126343 | SHIELD THERAPEUTICS INC | $32.16 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.